What question did this study set out to answer?

To identify and characterize protein biomarkers for cardiac amyloidosis using AI-driven methods.

December 8, 2025Blood

AI-based analysis reveals novel blood protein biomarkers for predicting cardiac amyloidosis approximately a decade early: A UK biobank study

View Full Paper

Ask AI

Bookmark

Authors

AI-based proteomic profiling reveals biomarkers for cardiac amyloidosis, suggesting early detection may improve outcomes.

To identify and characterize protein biomarkers for cardiac amyloidosis using AI-driven methods.
Analyzed large-scale proteomic data from UK Biobank to identify biomarkers.
Used statistical analyses and machine learning models including XGBoost and Limma.
Conducted univariate and predictive analyses to assess biomarker efficacy.
Identified specific protein biomarkers associated with cardiac amyloidosis.
Achieved a C-index of 0.81 for time-to-event prediction model.
Demonstrated temporal dynamics with AUROC values over several years.

Fieggen et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

AI-based proteomic profiling reveals biomarkers for cardiac amyloidosis, suggesting early detection may improve outcomes.

To identify and characterize protein biomarkers for cardiac amyloidosis using AI-driven methods.
Analyzed large-scale proteomic data from UK Biobank to identify biomarkers.
Used statistical analyses and machine learning models including XGBoost and Limma.
Conducted univariate and predictive analyses to assess biomarker efficacy.
Identified specific protein biomarkers associated with cardiac amyloidosis.
Achieved a C-index of 0.81 for time-to-event prediction model.
Demonstrated temporal dynamics with AUROC values over several years.

Fieggen et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark